Related Experiment Video
Updated: Jun 4, 2026

Using the E1A Minigene Tool to Study mRNA Splicing Changes
Published on: April 22, 2021
Alterations of pre-mRNA splicing in human inflammatory bowel disease
Robert Häsler1, Martin Kerick, Nancy Mah
1Institute of Clinical Molecular Biology, Christian-Albrechts-University, Schittenhelmstrasse 12, 24105 Kiel, Germany. r.haesler@mucosa.de
Abstract:
Alternative pre-mRNA splicing is regarded as a pivotal mechanism for generating proteome diversity and complexity from a limited inventory of mammalian genes. Aberrant splicing has been described as a predisposing factor for a number of diseases, but very little is known about its role in chronic inflammation. In this study, we systematically screened 149 splicing factors and 145 potential intron retention events for occurrence and differential expression in inflammatory bowel diseases (IBD). As a result, we identified 47 splicing factors and 33 intron retention events that were differentially regulated in mucosal tissue of IBD patients at transcript level. Despite the fact that Crohn's disease and ulcerative colitis, two subtypes of IBD, share the expression patterns of splicing factors and intron retention events in the majority of cases, we observed significant differences. To investigate these subtype-specific changes in detail we determined the expression levels of seven splicing factors (DUSP11, HNRPAB, HNRPH3, SLU7, SFR2IP, SFPQ, SF3B14) and three intron retention events (PARC, IER3, FGD2) in a cohort of 165 patients with inflammatory diseases of the colon (120 with IBD) and 30 healthy controls by real time PCR (TaqMan). This study demonstrates the potential impact of regulated splicing factors on subsequent regulated intron retention in the pathogenesis of chronic inflammation, exemplified by IBD.
Insights
Alternative pre-mRNA splicing plays a key role in chronic inflammation, particularly in inflammatory bowel diseases (IBD). This study identified numerous differentially regulated splicing factors and intron retention events in IBD patients, highlighting their pathogenic potential.
Area of Science:
- Molecular Biology
- Genetics
- Immunology
Background:
- Alternative pre-mRNA splicing generates proteome diversity.
- Aberrant splicing is linked to diseases, but its role in chronic inflammation is unclear.
- Inflammatory bowel diseases (IBD) are chronic inflammatory conditions.
Purpose of the Study:
- To investigate the role of alternative splicing in inflammatory bowel diseases (IBD).
- To identify differentially regulated splicing factors and intron retention events in IBD.
- To analyze subtype-specific splicing changes in Crohn's disease and ulcerative colitis.
Main Methods:
- Systematic screening of 149 splicing factors and 145 intron retention events in IBD mucosal tissue.
- Differential expression analysis at the transcript level.
- Validation of seven splicing factors and three intron retention events using real-time PCR in a cohort of 165 patients and 30 controls.
Main Results:
- Identified 47 splicing factors and 33 intron retention events differentially regulated in IBD.
- Observed shared and significant subtype-specific splicing changes between Crohn's disease and ulcerative colitis.
- Quantified expression levels of key splicing factors and intron retention events in inflammatory conditions.
Conclusions:
- Regulated splicing factors potentially impact subsequent intron retention in chronic inflammation pathogenesis.
- Alternative splicing alterations are implicated in the pathophysiology of IBD.
- This study provides insights into the molecular mechanisms underlying chronic inflammatory diseases.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Splicing
RNA Splicing
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Ulcerative Colitis
